Morning Read: Celgene and Juno ink $1B collaboration for T-cell therapeutics, pre-diabetes study shows willingness to make changes for health
A Juno and Celgene collaboration will focus on T cell therapeutics for cancer, one in eight people is pre-diabetic but a new study shows a willingness to change behavior if made aware of their risk.
- Pop culture misinterpretation of “fit foods” is spurring weight gain instead of weight loss
- From a snapshot of the mHealth investment landscape to defining population health: 5 must-read stories from MedCity News this week
- Wildflower Health raises $5M to expand mobile maternity apps for health plans
- Chicago mental health agency tries mobile care management with veterans